Reimagining the way maternity care is delivered and experienced
Investor Relations
HeraMED Limited (HMD:ASX) is a medical data and technology company leading the digital transformation of the prenatal and postpartum experience through our revolutionary remote monitoring and maternity care platform.
Pregnancy Care Reimagined
Our Technology
HeraMED’s technology has been recognized by major medical institutions, with collaborations underway with the Mayo Clinic and the Sheba Medical Center, two of the world’s top 10 hospitals.
Through its partnerships and investment in R&D, HeraMED continues to optimize and develop the next generation of its home-based maternity monitoring technology.
News
The latest from
HeraMED
HeraMED is the enabler of a paradigm shift - moving from the traditional, obsolete pregnancy care, which is visit and clinic centric, episodic and reactive, to the future of continuous, home-based, proactive care that focuses on the expecting mothers.
David Groberman, CEO HeraMED
Explore Our
ASX Announcements
28/10/2022 -
Change in substantial holding
27/10/2022 -
Ceasing to be a substantial holder
27/10/2022 -
Change of Director's Interest Notice
26/10/2022 -
Change in substantial holding
21/10/2022 -
Notice of Annual General Meeting/Proxy Form
20/10/2022 -
Restatement of CAPEX AUD amount on Investor Presentation
20/10/2022 -
Pause in Trading
19/10/2022 -
Global Update - Investor Presentation
19/10/2022 -
Global Update
20 / 20
